ParthShahMD

Hematologic Oncology

Physician

Dr. Shah is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

PubMed

1 citations
Development of hyperdiploidy starts at an early age and takes a decade to complete.
Mehmet K Samur, Anil Aktas Samur, Parth Shah, Joseph S Park, Mariateresa Fulciniti
Blood. 2025-01-30
A Splice Site Variant in SENP7 Results in a Severe Form of Arthrogryposis.
Udhaya Kotecha, Euri S Kim, Parth S Shah, Nidhi Shah, Vandana A Gupta
Clinical Genetics. 2025-01-04
Epigenetic Role of Long Non-coding RNAs in Multiple Myeloma.
Nikita Mehra, Subhiksha Sundaram, Parth Shah, Arunagiri Kuha Deva Magendhra Rao
Current Oncology Reports. 2025-01-01

Abstracts/Posters

Efficacy and Safety of Generic Imatinib Compared to Glivec in Chronic Phase - Chronic Myeloid Leukemia-Single Center Retrospective Analysis
Parth Shah, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019

Lectures

Why Is HPV Vaccine Uptake so Low in the United States?
ASCO Annual Meeting 2019 - Chicago, IL - 6/2/2019
VISTA Is a Novel Regulator of Macrophage Biology
61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019

Tip Sheet: HIV Exclusions in Clinical Trials; Lack of Diversity in Genetic Research; And Advances in Bladder CancerJuly 1st, 2019
How to Talk to Parents About HPV VaccinesJune 20th, 2019
Fred Hutch at ASCO: HPV Vaccine Uptake in U.S., Immunotherapy and Sarcoma, Financial Toxicity of Cancer, Health Care Disparities and MoreMay 28th, 2019